YM177 + etodolac + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post Operative Pain
Conditions
Post Operative Pain
Trial Timeline
Feb 1, 2010 → Nov 1, 2010
NCT ID
NCT01118572About YM177 + etodolac + Placebo
YM177 + etodolac + Placebo is a phase 3 stage product being developed by Astellas Pharma for Post Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01118572. Target conditions include Post Operative Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01118572 | Phase 3 | Completed |
Competing Products
20 competing products in Post Operative Pain